Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Etanercept

Known as: TNFR:Fc, Tumor necrosis factor receptor superfamily member 1B precursor, ETN 
A recombinant soluble dimeric fusion protein consisting of the extracellular ligand-binding region of recombinant human tumor necrosis factor (rhTNF… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
BACKGROUND The present review is part of the ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Biologic agents offer a range of new therapeutic options for patients with psoriasis; however, the relative benefit… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE Etanercept has been shown to improve the articular and cutaneous manifestations of psoriatic arthritis (PsA). In this… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Inflammatory cytokines such as tumor necrosis factor (TNF) have been implicated in the pathogenesis of psoriasis. We… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND & AIMS We evaluated etanercept, a human soluble tumor necrosis factor receptor: Fc fusion protein, for the treatment… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Etanercept, a tumour-necrosis-factor inhibitor, has shown efficacy in the treatment of rheumatoid arthritis. Psoriatic… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Etanercept, which blocks the action of tumor necrosis factor, reduces disease activity in patients with long-standing… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND We evaluated the safety and efficacy of etanercept, a soluble tumor necrosis factor receptor (p75):Fc fusion protein… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND Patients treated with methotrexate for rheumatoid arthritis often improve but continue to have active disease. This… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND In a phase II study, etanercept (recombinant human tumor necrosis factor receptor [p75]:Fc fusion protein) safely… Expand
Is this relevant?